SensDx

SensDx uses cookies to track visits to our website only, no personal information is collected. By continuing to use the site you are agreeing to our use of cookies.

Understood

SARS-CoV-2 test in development

We are working on expanding our test portfolio with rapid SARS-CoV-2 test, comparable in sensitivity and specificity to RT-PCR.

Precision result, test rapidity, ease of use

High Sensitivity

SensDx tests provide high sensitivity, comparable to the RT-PCR reference method. As the only one on the market, unlike the so-called “lateral flow” tests, it enables the detection of pathogen presence at an early stage of infection.

Simplicity and rapidity

SensDx tests are easy to use - the application guides the user step by step, which means that it can be done by anyone. No additional qualifications are required. The test result is obtained within 3-5 minutes.

Digital precision

The test analyses digital data, which allows for high reliability and continuous monitoring of the quality of the test. The result obtained in digital form can be printed out, sent to a selected recipient or archived in the system. Together with the result, the recipient receives a quality monitoring report of the test.

Our products are available across Poland!

We are growing! Our digital diagnostic platforms for influenza virus detection are now available in over 100 medical facilities across Poland!

Meet our medical facilities

Our products

SensDx is working on the technology of ultra-sensitive micorsensors, modified with biological molecules. The molecules on the electrode surface are selected by biotechnological methods. It allows you to identify unambiguously which bacteria or virus is the cause of infection or to determine the oncological marker, DNA or RNA.

Currently, works in the field of cardiology, oncology, urology and veterinary medicine are being carried out.

Available soon!

Multi SensDx - test for identification of upper respiratory tract infections causes

Multisensor is a rapid diagnostic test to identify the etiology of an upper respiratory tract infection that identifies more than one pathogen in a single sample. Proper diagnosis of the causes of the infection will allow for effective and precise therapy, which will reduce the unnecessary use of antibiotics in cases where the infection is viral.

News

SensDx receives Agency of Medical Research grant for SARS-CoV-2 test development

29/04/2020

SensDx has received positive grant recommendation from Agency of Medical Research for research and mass production implementation of SARS-CoV-2 diagnostics.

The first milestone achieved in developing a diagnostic test for coronavirus

11/03/2020

SensDx and the team of prof. Krzysztof Pyrc from Małopolska Centre of Biotechnology of the Jagiellonian University undertook joint activities to develop an ultrafast diagnostic test for SARS-CoV-2 virus (COVID-19).

Growing availability of our products across Poland!

11/12/2019

We are growing! Our digital diagnostic platforms for influenza virus detection are now available in over 100 medical facilities across Poland!

Proceed to archive

Vision

Our vision is to revolutionize medical diagnosis worldwide by providing effective, rapid and easy-to-use tests to detect pathogens causing specific diseases.

Mission

Our mission is to prevent the spreading of bacteria and viruses by detecting pathogens at an early stage of development.

Technology

The innovative solution combines a simple tool based on a fast, ultra-sensitive diagnostic test with a mobile application for easy result interpretation.

Tests

The test tools are placed inside specially-designed devices called Mobi (for individual patients) or Pro (for medical professionals)

Team

SensDX comprises of an interdisciplinary team of experts specialising in biotechnological, chemical, electrochemical and electronic sciences, IT, production automation and business, including IP protection, technology commercialisation, sales and marketing. We work in line with modern management methods, high quality standards and safety regulations.

Accomplishments

The dynamic growth of SensDx has been facilitated by funds obtained through a wide range of subsidies. While evaluating the SensDx applications, experts appreciated not only the technology, which will have a wide range of applications in telemedicine and diagnostics, but also the innovative functionality, huge commercialisation potential and business model, implemented consistently by SensDx.

Learn more